Skip to main content
SpringerLink
Log in

Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study

  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Summary

  1. 1.

    Concentrations of the neurotransmitter amines noradrenaline (NA), dopamine (DA), and 5-hydroxytryptamine (5-HT) and the acid metabolites homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) were determined in four regions of postmortem brains of demented patients with or without Alzheimer's disease (AD).

  2. 2.

    NA was deficient in the temporal cortex (BA 21) of AD, but not of non-AD, patients.

  3. 3.

    Caudate, in particular, had an impaired dopaminergic system in AD patients, with low HVA levels.

  4. 4.

    In all regions investigated [amygdala, caudate, putamen, temporal cortex (BA 21)] 5-HT was significantly depleted in AD patients, and 5-HIAA was also depleted in amygdala and caudate.

  5. 5.

    These results indicate that neurotransmitter systems other than cholinergic systems are also widely affected in AD and suggest that these deficits may also play an important role in determining the symptomatology of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adolfsson, R., Gottfries, C. G., Roos, B. E., and Winblad, B. (1979). Changes in the brain catecholamines in patients with dementia of Alzheimer type.Br. J. Psychiat. 135216–223.

    Google Scholar 

  • Arai, H., Kosaka, K., and Iizuka, R. (1984). Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.J. Neurochem. 43388–393.

    Google Scholar 

  • Baker, G. B., and Reynolds, G. P. (1989). Biogenic amines and their metabolites in Alzheimer's disease: Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.Neurosci. Lett. 100335–339.

    Google Scholar 

  • Bondareff, W., Mountjoy, C. Q., and Roth, M. (1981). Selective loss of neurons of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.Lancet,1783–784.

    Google Scholar 

  • Bowen, D. M., Allen, S. J., Benton, J. S., Goodhardt, M. J., Haan, E. A., Palmer, A. M., Sims, N. R., Smith, C. C. T., Spillane, J. A., Esiri, M. M., Neary, D., Snowdon, J. S., Wilcock, G. K., and Davison, A. N. (1983). Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.J. Neurochem. 41266–272.

    Google Scholar 

  • Cross, A. J., Crow, T. J., Perry, E. K., Perry, R. H., Blessed, G., and Tomlinson, B. E. (1981). Reduced dopamineβ-hydroxylase activity in Alzheimer's disease.Br. Med. J. 28293–94.

    Google Scholar 

  • Cross, A. J., Crow, T. J., Johnson, J. A., Joseph, M. H., Perry, E. K., Perry, R. H., Blessed, G., and Tomlinson, B. E. (1983). Monoamine metabolism in senile dementia of Alzheimer type.J. Neurol. Sci. 60383–392.

    Google Scholar 

  • Davies, P., and Maloney, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease.Lancet 21403.

    Google Scholar 

  • Davies, P., Katzman, R., and Terry, R. D. (1980). Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia.Nature 288279–280.

    Google Scholar 

  • DeJong, R. N., and Pope, A. (1975). Complex cerebral functions. InThe Nervous System, Clinical Neurosciences, Vol. 2 (D. B. Tower and T. N. Chase, Eds.), Raven Press, New York, pp. 449–456.

    Google Scholar 

  • Ferrier, I. N., Cross, A. J., Johnson, J. A., Roberts, G. W., Crow, T. J., Corsellis, J. A. N., Lee, Y. C., O'Shaughnessy, D., Adrian, T. E., McGregor, G. P., Baracese-Hamilton, A. J., and Bloom, S. R. (1983). Neuropeptides in Alzheimer type dementia.J. Neurol. Sci. 62159–170.

    Google Scholar 

  • Gottfries, C. G. (1979). Amine metabolism in normal ageing and in dementia disorders. InBiochemistry of Dementia (P. J. Roberts, Ed.), John Wiley and Sons, Chichester, pp. 213–234.

    Google Scholar 

  • Gottfries, C. G. (1981). Levels of monoamines, monoamine metabolites and activity in related enzyme systems correlated to normal ageing and in patients with dementia of Alzheimer type. InApomorphine and Other Dopaminomimetics, Clinical Pharmacology, Vol. 2 (G. U. Corsini and G. L. Gessa, Eds.), Raven Press, New York, pp. 243–249.

    Google Scholar 

  • Gottfries, C. G. (1990). Neurochemical aspects of dementia disorders.Dementia 156–64.

    Google Scholar 

  • Gottfries, C. G., Adolfsson, R., Aquilonius, S. M., Carlsson, A., Oreland, L., Svennerholm, L., and Winblad, B., (1980). Parkinsonism and dementia disorders of the Alzheimer type: Similarities and differences. InParkinson's Disease—Current Progress, Problems and Management (U. K. Rhinne, M. Klingler, and G. Stamm, Eds.), Elsevier/North-Holland Biomedical Press, Amsterdam, pp. 197–208.

    Google Scholar 

  • Gottfries, C. G., Adolfsson, R., Aquilonius, S. M., Carlsson, A., Eckernas, S. A., Nordberg, A., Oreland, L., Svennerholm, L., Wiberg, A., and Winblad, B., (1983). Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).Neurobiol. Aging 4 261–271.

    Google Scholar 

  • Hardy, J., Adolfsson, R., Alafuzoff, I., Bucht, G., Marcusson, J., Nyberg, P., Perdahl, E., Wester, P., and Winblad, B. (1985). Transmitter deficits in Alzheimer's disease.Neurochem. Int. 7545–563.

    Google Scholar 

  • Ishii, T. (1966). Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia.Acta Neuropathol. (Berl.)6181–187.

    Google Scholar 

  • Iversen, L. L., Rossor, M. N., Reynolds, G. P., Hills, R., Roth, M., Mountjoy, C. Q., Foote, S. L., Morrison, J. H., and Bloom, F. E. (1983). Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.Neurosci. Lett. 3995–100.

    Google Scholar 

  • Mann, D. M. A., Lincoln, J., Yates, P. O., Stamp, J. E., and Toper, S. (1980). Changes in the monoamine containing neurones of the human CNS in senile dementia.Br. J. Psychiat. 136533–541.

    Google Scholar 

  • Mann, D. M. A., Yates, P. O., and Hawkes, J. (1982). The noradrenergic system in Alzheimer and multi-infarct dementias.J. Neurol. Neurosurg. Psychiat. 45113–119.

    Google Scholar 

  • Pearce, J. (1974). Mental changes in Parkinsonism.Br. Med. J. 2445.

    Google Scholar 

  • Perry, E. K. (1987). Cortical neurotransmitter chemistry in Alzheimer's disease. InPsychopharmacology: The Third Generation of Progress, (H. Y. Meltzer, Ed.), Raven Press, New York, pp. 887–895.

    Google Scholar 

  • Perry, E. K., Perry, R. H., Blessed, G., and Tomlinson, B. E. (1977). Necropsy evidence of central cholinergic deficits in senile dementia.Lancet 1189.

    Google Scholar 

  • Quirion, R., Martel, J. C., Robitaille, Y., Etienne, P., Wood, P., Nair, N. P. V., and Gautheir, S. (1986). Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.Can. J. Neurol. Sci. 13503–510.

    Google Scholar 

  • Reynolds, G. P. (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia.Nature 305527–529.

    Google Scholar 

  • Reynolds, G. P., Arnold, L., Rossor, M. N., Iversen, L. L., Mountjoy, C. Q., and Roth, M. (1984). Reduced binding of [3H]-ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type.Neurosci. Lett. 4447–51.

    Google Scholar 

  • Rossor, M. N. (1982). Dementia.Lancet 21200–1204.

    Google Scholar 

  • Rossor, M., and Iversen, L. L. (1986). Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.Br. Med. Bull. 4270–74.

    Google Scholar 

  • Rossor, M. N., Emson, P. C., Mountjoy, C. Q., Roth, M., and Iversen, L. L. (1980). Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.Neurosci. Lett. 20373–377.

    Google Scholar 

  • Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease.Neuron 6487–498.

    Google Scholar 

  • Spillane, J. A., White, P., Goodhardt, M. J., Flack, R. H. A., Bowen, D. M., and Davison, A. N. (1977). Selective vulnerability of neurons in organic dementia.Nature 266558–559.

    Google Scholar 

  • Spokes, E. G. S. (1979). An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human postmortem brain tissue.Brain 102333–346.

    Google Scholar 

  • Tomlinson, B. E., and Corsellis, J. A. N. (1984). Ageing and the dementias. InGreenfield's Neuropathology 4th ed. (J. H. Adams, J. A. N. Corsellis, and L. W. Duchen, Eds.), J. Wiley, New York, pp. 951–1025.

    Google Scholar 

  • Tomlinson, B. E., Irving, D., and Blessed, G. (1981). Cell loss in the locus coeruleus in senile dementia of Alzheimer type.J. Neurol. Sci. 49419–428.

    Google Scholar 

  • Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., and Delong, M. R. (1981). Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis.Ann. Neurol. 10122–126.

    Google Scholar 

  • Winblad, B., Adolfsson, R., Carlsson, A., and Gottfries, C. G. (1982). Biogenic amines in brains of patients with Alzheimer's disease. InAlzheimer's Disease: A Report of Progress in Research, Vol. 19 (S. Corkin, K. L. Davis, J. H. Growdon, E. Usdin, and R. J. Wurtman, Eds.), Raven Press, New York, pp. 25–33.

    Google Scholar 

Download references

Author information

Author notes

  1. Gavin P. Reynolds

    Present address: Department of Biomedical Science, The University of Sheffield, Sheffield, U.K.

Authors and Affiliations

  1. Department of Pathology, Queens Medical Centre, Nottingham, England

    Adil J. Nazarali & Gavin P. Reynolds

Authors
  1. Adil J. Nazarali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gavin P. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nazarali, A.J., Reynolds, G.P. Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study. Cell Mol Neurobiol 12, 581–587 (1992). https://doi.org/10.1007/BF00711237

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00711237

Key words

Search

Navigation